Vallon Pharmaceuticals Operating Income

Vallon Pharmaceuticals (VLON) currently reports a operating income of $-6.9M as of September 2024. That compares with $-12M in the prior-year period — up 43.0% year over year. Use the charts on this page to explore Vallon Pharmaceuticals's operating income history and peer comparisons.

Vallon Pharmaceuticals's operating income increased from $-12M to $-6.9M — a 43.0% year-over-year increase (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vallon Pharmaceuticals reported $-6.9M in operating income as of September 2024. That compares with $-12M in the prior-year period — up 43.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-6.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vallon Pharmaceuticals, and consider following VLON for alerts when major investors trade the stock.

Vallon Pharmaceuticals is classified in the Healthcare sector. On operating income, it currently shows $-6.9M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VLON with unrelated industries.